MHC II immunogenicity shapes the neoepitope landscape in human tumors

ABSTRACT: DeepNeo predicts immunogenic neoantigens for both MHC I and II responsive to immune checkpoint blockade therapy. Furthermore, spontaneous immunity was observed in pancancer manner for MHC II.

INSTRUMENT(S): -

ORGANISM(S): Homo Sapiens

SUBMITTER: KAIST 

PROVIDER: PRJEB57400 | EVA | 2022-11-14

REPOSITORIES: EVA